The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling

被引:31
作者
Maile, LA [1 ]
Busby, WH [1 ]
Sitko, K [1 ]
Capps, BE [1 ]
Sergent, T [1 ]
Badley-Clarke, J [1 ]
Ling, Y [1 ]
Clemmons, DR [1 ]
机构
[1] Univ N Carolina, Div Endocrinol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1210/me.2005-0382
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have shown that vitronectin (Vn) binding to a cysteine loop sequence within the extracellular domain of the beta 3-subunit ( amino acids 177 - 184) of alpha V beta 3 is required for the positive effects of Vn on IGF-I signaling. When Vn binding to this sequence is blocked, IGF-I signaling in smooth muscle cells is impaired. Because this binding site is distinct from the site on beta 3 to which the Arg-Gly-Asp sequence of extracellular matrix ligands bind ( amino acids 107 - 171), we hypothesized that the region of Vn that binds to the cysteine loop on beta 3 is distinct from the region that contains the Arg-Gly-Asp sequence. The results presented in this study demonstrate that this heparin binding domain (HBD) is the region of Vn that binds to the cysteine loop region of beta 3 and that this region is sufficient to mediate the positive effects of Vn on IGF-I signaling. We provide evidence that binding of the HBD of Vn to alpha V beta 3 has direct effects on the activation state of beta 3 as measured by beta 3 phosphorylation. The increase in beta 3 phosphorylation associated with exposure of cells to this HBD is associated with enhanced phosphorylation of the adaptor protein Src homology 2 domain-containing transforming protein C and enhanced activation MAPK, a downstream mediator of IGF-I signaling. We conclude that the interaction of the HBD of Vn binding to the cysteine loop sequence of beta 3 is necessary and sufficient for the positive effects of Vn on IGF-I-mediated effects in smooth muscle cells.
引用
收藏
页码:881 / 892
页数:12
相关论文
共 32 条
[1]   Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I in response to heparin [J].
Arai, T ;
Clarke, J ;
Parker, A ;
Busby, W ;
Nam, T ;
Clemmons, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6099-6106
[2]   Integrin β3 regions controlling binding of murine mAb 7E3:: Implications for the mechanism of integrin αIIbβ3 activation [J].
Artoni, A ;
Li, JH ;
Mitchell, B ;
Ruan, J ;
Takagi, J ;
Springer, TA ;
French, DL ;
Coller, BS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13114-13120
[3]   The contradictions of the insulin-like growth factor 1 receptor [J].
Baserga, R .
ONCOGENE, 2000, 19 (49) :5574-5581
[4]   Synthetic αVβ3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication [J].
Clemmons, DR ;
Horvitz, G ;
Engleman, W ;
Nichols, T ;
Moralez, A ;
Nickols, GA .
ENDOCRINOLOGY, 1999, 140 (10) :4616-4621
[5]   alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines [J].
Falcioni, R ;
Antonini, A ;
Nistico, P ;
DiStefano, S ;
Crescenzi, M ;
Natali, PG ;
Sacchi, A .
EXPERIMENTAL CELL RESEARCH, 1997, 236 (01) :76-85
[6]   INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEINS INHIBIT THE SMOOTH-MUSCLE CELL-MIGRATION RESPONSES TO IGF-I AND IGF-II [J].
GOCKERMAN, A ;
PREVETTE, T ;
JONES, JI ;
CLEMMONS, DR .
ENDOCRINOLOGY, 1995, 136 (10) :4168-4173
[7]  
Goel HL, 2004, J CELL BIOL, V166, P407, DOI 10.1083/jcb.200403003
[8]   Integrins: Bidirectional, allosteric signaling machines [J].
Hynes, RO .
CELL, 2002, 110 (06) :673-687
[9]   Ligand occupancy of the alpha V beta 3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor I [J].
Jones, JI ;
Prevette, T ;
Gockerman, A ;
Clemmons, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2482-2487
[10]   Fluid shear stress synergizes with insulin-like growth factor-I (IGF-I) on osteoblast proliferation through integrin-dependent activation of IGF-I mitogenic signaling pathway [J].
Kapur, S ;
Mohan, S ;
Baylink, DJ ;
Lau, KHW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) :20163-20170